Pityriasis rubra pilaris successfully treated with infliximab.
Ruiz-Genao
Diana P
DP
Lopez-Estebaranz
Jose Luis
JL
Naz-Villalba
Elena
E
Gamo-Villegas
Reyes
R
Calzado-Villarreal
Leticia
L
Pinedo-Moraleda
Fernando
F
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D000069285:Infliximab; D007262:Infusions, Intravenous; D008875:Middle Aged; D010916:Pityriasis Rubra Pilaris / Q000188:drug therapy* / Q000473:pathology; D012867:Skin / Q000473:pathology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000911:Antibodies, Monoclonal; D007155:Immunologic Factors; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab